Douyin Live Stream Coverage | Qirui’s 2020 Annual Work Summary and Awards Ceremony Held Successfully!
Category: News and Information
Release Date: 2021-01-28
Summary:

The annual company work-summary and recognition conference is always a milestone worth documenting. In response to national epidemic-prevention and control requirements, on the afternoon of January 20, the company held its 2020 “Rekindling the ‘Rui’ Banner, Sailing Together Toward Shared Success” gala via Douyin livestream. The event emphasized its livestream format, aimed to energize and inspire participants, and encouraged full staff engagement, creating a truly delightful audiovisual feast.
This grand event featured bold innovations. First, for the first time, it was live-streamed on Douyin worldwide and across the entire company, attracting a record-breaking on-site attendance while maintaining over 400 concurrent online viewers. Second, a video chronicling the company’s two-decade journey was edited for the first time, offering a retrospective of these remarkable twenty years of dedicated effort and achievement. Third, messages from all senior executives and general managers of each business unit were recorded for the first time—providing the best source of positive energy and the most effective form of corporate education for all employees. Fourth, representatives of the company’s management delivered impassioned poetry recitations, conveying the mission and responsibilities of the new era. The entire event was the result of collective brainstorming and collaboration, with planning, creative concept development, and execution spanning two months.
In accordance with epidemic prevention and control requirements, the number of on-site attendees at this meeting has been strictly limited. The training room on the third floor of Zhongyou Pharmaceutical served as the venue, while all employees of Qirui Technology, Qirui Pharmaceutical, Zhongyou Pharmaceutical, Langlai Technology, Shanghai Meiyue, Shandong Ruiyin, and other Qirui entities gathered virtually via live stream.
Douyin Live: On-Site at the Conference
Segment 1: Opening Video
To mark Qirui’s 20th anniversary, the short video “Qirui’s 20-Year Retrospective” thoughtfully highlights a selection of milestone events from each year.
Session 2: Work Summary and Award Decision
Work Summary: Mr. Yu Xuechen
Commendation Decision: Ms. Liu Peipei
Mr. Yu Xuechen, Deputy Director of the General Office of Qirui Group, delivered the “2020 Annual Work Summary Report” on behalf of the company, while Ms. Liu Peipei, Head of the Human Resources Department of Qirui Group, announced the “Decision on Commending Outstanding Individuals and Teams of Qirui Group for 2020.”
Segment 3: Acceptance Speech
Mr. Feng Wei, Medical Team, Qirui Technology
Ten representatives—Feng Wei from Qirui Technology’s Medical Division and Li Chengcheng, Wang Xiaoxiong, Peng Yangqiao, Zhang Xuejia, Yang Bingbing, and others from Langlai’s Finance Team—took the stage to deliver their acceptance speeches.
Crystallization and Drying Section, Pharmaceutical Workshop, Wang Xiaoxiong
Wang Xiaoxiong, the spokesperson for the Crystallization and Drying Group of Qirui Pharmaceutical’s API Workshop—recipient of one of the “Team of Champions” awards—said, “Over the past eight years, the two concepts that have left the deepest impression on me are ‘system’ and ‘operations.’ As a manager, I must always approach problem-solving with a systematic mindset. Achieving operational objectives requires a robust system as its foundation, and the essence of a system is the organization. An organization needs to be empowered; it requires processes, policies, and standards to guide behavior and measure outcomes. Ultimately, the organization’s goal is to achieve victory in the field.”
CMC Compliance Management Team, Peng Yangqiao
Peng Yangqiao, a management elite who has dedicated ten years to the company, said from the bottom of his heart: “As members of Qirui, whether we are frontline employees holding steady in our ordinary roles or managerial cadres at the corporate level, as long as we are willing to put in the effort and stay grounded, and as long as we never lose sight of our original commitment to stand together with Qirui through thick and thin, the company will surely recognize and reward such dedication. Moreover, the company is fully committed to entrusting those who truly deserve its trust with more critical and high-impact assignments, so that we can move forward hand in hand in pursuit of the company’s continued growth.”
Speech by an Outstanding Employee
Langlai Technology, Li Chengcheng
Langlai Technology, Wu Wei
Zhongyou Pharmaceutical, Yang Bingbing
Langlai Technology, Wang Heng
Qirui Pharmaceutical, Hu Zhixia
Fourth Segment: Poetry Recitation
"Uniting as One, Pressing On with Determination"

Representatives of the company’s management—General Managers Cao Yi, Li Dajiong, Zhang Wei, and Zhang Yihan, as well as General Manager Wang Jianjun, Director Liu Peipei, and Deputy Director Yu Xuechen—delivered a heartfelt recitation of “Uniting as One, Pressing On with Determination,” conveying the core value of “quality responsibility” and the spirit of pursuing dreams through rigorous attention to detail, pioneering innovation, and relentless striving.
Fifth Session Chairman’s Address
Chairman Wang Chaodong
Finally, Chairman Wang Chaodong delivered a New Year message, extending his heartfelt congratulations to the outstanding collectives and exemplary employees honored at this event. He also offered guiding remarks on organizational development and expressed full recognition and high praise for the work accomplished by the leadership teams across all business units. The Chairman particularly emphasized that everyone should approach the new year with unwavering faith, an objective and balanced perspective on the world, gratitude for the present moment, and a positive, compassionate intention as they move forward into 2021.
Excerpt from the Chairman’s Address:
Upholding the core values of quality and responsibility, we have, with a scientific, rigorous, and meticulous approach and extraordinary courage, successively won the tough battles against the epidemic and in resuming work and production.
We are committed to realizing our vision of building Qirui into a leading exemplar of innovation in the pharmaceutical industry by steadfastly driving organizational transformation, iteratively refining our management approaches, prioritizing talent development, and continuously enhancing organizational effectiveness.
We are committed to delivering high-quality, specialized products and services that advance human health. To this end, we continue to increase our investment in innovation, accelerate the modernization of our equipment and facilities, and deepen reforms of our business models, with initial results already evident in our product portfolio.
Long-term expectations of the board:
We hope that our organizational functions will be further refined and that organizational effectiveness will continue to improve.
We hope that our cadre team will continue to grow in size and that a steady stream of key talent will keep emerging.
We hope that our business acumen will continue to improve and that the commercialization of our research outcomes will yield widespread, multi-faceted results.

Wishing all of us at Qirui a happy and prosperous future!
The ox turns the tide, fortune rides high, and the Year of the Ox brings great luck!
Keywords: Douyin Live Stream Coverage | Qirui’s 2020 Annual Work Summary and Awards Ceremony Held Successfully!
Related News Centers
Academic Column
Development History
-
2019
Release time:2023-01-05
-
2018
Release time:2023-01-05
-
2017
Release time:2023-01-05
-
2014
Release time:2023-01-05
-
2013
Release time:2023-01-05
-
2012
Release time:2023-01-05
-
2011
Release time:2023-01-05
-
2010
Release time:2023-01-05
-
2009
Release time:2023-01-05
-
2008
Release time:2023-01-05
-
2007
Release time:2023-01-05
-
2006
Release time:2023-01-05
-
2005
Release time:2023-01-05
-
2004
Release time:2022-12-30
-
2003
Release time:2022-12-30
Branch office
News and Information
-
Qirui Group’s First Innovative Drug, MY008211A Tablets (Lanocapam Hydrochloride Tablets), Successfully Achieves the Primary Efficacy Endpoint in Phase III Clinical Trials
Release time:2026-02-25
-
Qirui Group’s First Innovative Drug Passes Both National Key Inspections on the First Attempt
Release time:2026-01-27
-
Three Employees of Qirui Pharmaceutical Awarded Jiangxia District’s Tangxun Lake Talent Recognition!
Release time:2026-01-15
-
“A ‘Start’ That Stands Out, Bringing in Talented Young Professionals — Qirui Group’s 2026 Campus Recruitment Concludes Successfully”
Release time:2025-12-31
-
Qirui Pharmaceutical’s Ganyining® Ademetionine Disulfonate for Injection Wins Bid in the 11th National Centralized Procurement Round
Release time:2025-11-11
-
Qirui Group Makes Its Debut at the 17th Bio-Industry Conference
Release time:2025-09-08
-
Empowering Your Journey, Illuminating the Path Ahead—Qirui Group’s 2025 New Graduate Onboarding Program Concludes Successfully
Release time:2025-07-23
-
Internationally Accredited! Qirui Technology Earns ACCA Recognized Employer Status
Release time:2025-07-08
-
Safeguarding the Source of Life and Fortifying the Quality Defense Line for Pharmaceutical Water — Professional Training on Purified Water Systems at Qirui Pharmaceutical
Release time:2025-06-05
-
Wuhan Qirui Technology Development Co., Ltd. Donates RMB 100 Million to Huazhong University of Science and Technology
Release time:2025-03-17
-
People-Oriented, Win-Win Future | Qirui Pharmaceutical Honored as “2024 China’s Top Employer”
Release time:2025-02-18
-
Empowering Party Building to Unite New Forces, Achieve Synergy, and Expand “Health”
Release time:2024-07-10
-
Qirui Group Makes Its Debut at CPHI China 2024
Release time:2024-06-28
-
Enhancing Competence Through Competition and Pursuing Development Through Quality: Qirui Pharmaceutical Successfully Holds Its 2024 Annual Quality Knowledge Competition
Release time:2024-06-28
-
Shining with the Light of Wisdom, Passing on the Torch of Scholarship — The Joint Master’s Thesis Defense Ceremony between Qirui Pharmaceutical and China Pharmaceutical University Concludes Successfully
Release time:2024-06-07
-
Academic Gala | The 8th International Forum on Drug-Induced Liver Injury Concludes Successfully; Ornithine Aspartate Recommended in the “Chinese Guidelines for Primary Care Diagnosis and Management of Drug-Induced Liver Injury (2024)”
Release time:2024-05-31
-
Qirui Pharmaceutical Awarded the “Wuhan May Day Labor Medal”
Release time:2024-05-13
-
Qirui Pharmaceutical Selected for Inclusion in the 2023 Jiangxia District List of Proposed Projects for District-Level Technology Transfer and Key R&D Initiatives
Release time:2024-04-12
-
“Made in Wuhan” Generic Drugs Added to the 2020 National Reimbursement Drug List
Release time:2021-03-05
-
Congratulatory Letter to Shandong Ruiyin Bioengineering Co., Ltd.
Release time:2021-02-01
-
Douyin Live Stream Coverage | Qirui’s 2020 Annual Work Summary and Awards Ceremony Held Successfully!
Release time:2021-01-28
-
First Public Notice of the Environmental Impact Assessment for the Demonstration Project on the Transformation and Construction of a Multi-Functional, Intelligent, Safe, Green, and High-End Active Pharmaceutical Ingredient Production Platform and Pilot-Scale Service Platform at Wuhan Zhongyou Pharmaceutical Co., Ltd.
Release time:2020-06-28
-
Decision on Commending the 2020 Pioneers in Epidemic Prevention Responsibility and Model Workers in Resuming Work and Production
Release time:2020-05-11
-
Notice of the Renewal of the Employee Care and Corporate Culture Development Committee
Release time:2020-04-27
Sunshine Avenue, Sunshine Third Road, Miaoshan Subdistrict, Economic Development Zone, Jiangxia District, Wuhan, Hubei Province
QR code
Copyright © Wuhan Qirui Pharmaceutical Co., Ltd. |Privacy Policy
Powered by www.300.cn
This website supports IPv6.